BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 14985534)

  • 1. Covalent disulfide-linked anti-CEA diabody allows site-specific conjugation and radiolabeling for tumor targeting applications.
    Olafsen T; Cheung CW; Yazaki PJ; Li L; Sundaresan G; Gambhir SS; Sherman MA; Williams LE; Shively JE; Raubitschek AA; Wu AM
    Protein Eng Des Sel; 2004 Jan; 17(1):21-7. PubMed ID: 14985534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice.
    Sundaresan G; Yazaki PJ; Shively JE; Finn RD; Larson SM; Raubitschek AA; Williams LE; Chatziioannou AF; Gambhir SS; Wu AM
    J Nucl Med; 2003 Dec; 44(12):1962-9. PubMed ID: 14660722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of an αvβ6-specific diabody and a disulfide-stabilized αvβ6-specific cys-diabody.
    White JB; Boucher DL; Zettlitz KA; Wu AM; Sutcliffe JL
    Nucl Med Biol; 2015 Dec; 42(12):945-57. PubMed ID: 26341848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of colorectal cancer in xenograft-bearing mice by use of an 18F-labeled T84.66 anti-carcinoembryonic antigen diabody.
    Cai W; Olafsen T; Zhang X; Cao Q; Gambhir SS; Williams LE; Wu AM; Chen X
    J Nucl Med; 2007 Feb; 48(2):304-10. PubMed ID: 17268029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and t84.66 minibody: comparison to radioiodinated fragments.
    Yazaki PJ; Wu AM; Tsai SW; Williams LE; Ikler DN; Wong JY; Shively JE; Raubitschek AA
    Bioconjug Chem; 2001; 12(2):220-8. PubMed ID: 11312683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specific conjugation of monodispersed DOTA-PEGn to a thiolated diabody reveals the effect of increasing peg size on kidney clearance and tumor uptake with improved 64-copper PET imaging.
    Li L; Crow D; Turatti F; Bading JR; Anderson AL; Poku E; Yazaki PJ; Carmichael J; Leong D; Wheatcroft D; Raubitschek AA; Hudson PJ; Colcher D; Shively JE
    Bioconjug Chem; 2011 Apr; 22(4):709-16. PubMed ID: 21395337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved biodistribution and radioimmunoimaging with poly(ethylene glycol)-DOTA-conjugated anti-CEA diabody.
    Li L; Yazaki PJ; Anderson AL; Crow D; Colcher D; Wu AM; Williams LE; Wong JY; Raubitschek A; Shively JE
    Bioconjug Chem; 2006; 17(1):68-76. PubMed ID: 16417253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of kidney uptake in radiometal labeled peptide linkers conjugated to recombinant antibody fragments. Site-specific conjugation of DOTA-peptides to a Cys-diabody.
    Li L; Olafsen T; Anderson AL; Wu A; Raubitschek AA; Shively JE
    Bioconjug Chem; 2002; 13(5):985-95. PubMed ID: 12236780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CEA antibody fragments labeled with [(18)F]AlF for PET imaging of CEA-expressing tumors.
    Lütje S; Franssen GM; Sharkey RM; Laverman P; Rossi EA; Goldenberg DM; Oyen WJ; Boerman OC; McBride WJ
    Bioconjug Chem; 2014 Feb; 25(2):335-41. PubMed ID: 24382090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers.
    Wu AM; Chen W; Raubitschek A; Williams LE; Neumaier M; Fischer R; Hu SZ; Odom-Maryon T; Wong JY; Shively JE
    Immunotechnology; 1996 Feb; 2(1):21-36. PubMed ID: 9373325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for
    Zettlitz KA; Waldmann CM; Tsai WK; Tavaré R; Collins J; Murphy JM; Wu AM
    J Nucl Med; 2019 Oct; 60(10):1467-1473. PubMed ID: 30877181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific, thiol-mediated conjugation of fluorescent probes to cysteine-modified diabodies targeting CD20 or HER2.
    Sirk SJ; Olafsen T; Barat B; Bauer KB; Wu AM
    Bioconjug Chem; 2008 Dec; 19(12):2527-34. PubMed ID: 19053310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fusion of Gaussia luciferase to an engineered anti-carcinoembryonic antigen (CEA) antibody for in vivo optical imaging.
    Venisnik KM; Olafsen T; Gambhir SS; Wu AM
    Mol Imaging Biol; 2007; 9(5):267-77. PubMed ID: 17577599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs in V(L)-to-V(H) orientation: implications for diabody flexibility.
    Carmichael JA; Power BE; Garrett TP; Yazaki PJ; Shively JE; Raubischek AA; Wu AM; Hudson PJ
    J Mol Biol; 2003 Feb; 326(2):341-51. PubMed ID: 12559905
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.